523 Crystallization of Pharmaceutical and Biological Molecules II

Wednesday, November 16, 2016: 12:30 PM - 3:00 PM
Cyril Magnin III (Parc 55 San Francisco)
This session welcomes papers addressing fundamental as well as applied studies in the area of crystallization of pharmaceutical or biological molecules. Topics related to experimental studies, theory and simulation that contribute to fundamental understanding of crystallization as well as industrial case studies on the crystallization development of pharmaceutical and biological compounds are encouraged.

Crystallization and Evaporation


12:30 PM
Welcoming Remarks

12:35 PM
(523a) Understanding the Impact of Bile Salts on Crystallization Kinetics of Supersaturated Solutions of a Poorly Water Soluble Compound
Jennifer Lu, James D. Ormes, Michael Lowinger, Wei Xu, Amitava Mitra, James D. Litster and Lynne S. Taylor

12:55 PM
(523b) Crystallization Design: A Case Study on an Active Pharmaceutical Ingredient (API)
Nathaniel D. Kopp, Chester E. Markwalter, Andrew Glace, Maria Sandoval, Collin Chan, Michael Smith and Lindsay Hobson

1:15 PM
(523c) Design of Continuous Enzymatic Reactive Crystallization for Beta-Lactam Antibiotic Synthesis
Matthew A. McDonald, Andreas S. Bommarius and Ronald W. Rousseau

2:15 PM
(523f) Microwave-Assisted Evaporative Crystallization for Enhancing Physicochemical Properties of Pharmaceuticals By Size Reduction
Norbert Radacsi, Rita Ambrus, Piroska Szabo-Revesz, G. D. Stefanidis and J.H. ter Horst

2:35 PM
Concluding Remarks
See more of this Group/Topical: Separations Division